Electroconvulsive therapy in the era of modern psychopharmacology
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Fifty years of advances in the pharmacotherapy of major depression (MDE), mania, schizophrenia, and other severe and persistent psychiatric disorders have neither made ECT obsolete nor unnecessary. However, advances in pharmacotherapy have radically changed the practice of ECT. ECT is rarely a first-line treatment of mental disorder, unless the clinical situation is desperate. Otherwise, ECT is most often offered to persons who have failed to respond to pharmacotherapy, thus defining a relatively treatment-refractory population for ECT. The physician who refers patients for ECT, as well as the ECT provider, must be able to judge at what point a patient is deemed "medication resistant", implying expertise in pharmacotherapy for both the referring physician and the ECT provider. Authoritative sources from 20 years ago quoted antidepressant response rates > or = 90% for ECT, but the antidepressant response rate in medication-resistant MDE may be only 60%. Improvements in the safety of ECT have resulted in the referral of large numbers of older persons for ECT. High relapse rates after ECT are perhaps the biggest problem presently facing patients and providers. High relapse rates are not surprising given that (i) most patients are medication resistant, and (ii) ECT is usually withdrawn at the moment it becomes effective. Although continuation/maintenance ECT is an option in preventing relapse, it may not be a practical solution for persons still in their productive years, and it is resource-intensive. Still, continuation/maintenance ECT is the only method to prevent relapse and recurrence of severe psychiatric disorder for some persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686
Serotonin Reuptake Inhibitor Withdrawal
Coupland, N. J., Bell, C. J., & Potokar, J. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00003 · Cited by 303 · cited 1×
“A second reason to continue antidepressants (especially SSRIs) during ECT is that abrupt withdrawal of antidepressants may produce a withdrawal syndrome that could cloud the results of ECT (Coupland et al., 1996).”
Background
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Contemporary use and practice of electroconvulsive therapy worldwide
Leiknes, K. A., Schweder, L. J., & Høie, B. (2012) · Brain and Behavior · doi:10.1002/brb3.37 · Cited by 380
Schulze-Rauschenbach, S. C., Harms, U., Schlaepfer, T. E., Maier, W., Falkai, P., & Wagner, M. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.5.410 · Cited by 122
“The rates of those responding to unilateral ECT are in the expected range for medication-resistant non-psychotic depression (McCall, 2001), but might have been higher if a higher ECT dosage had been used (Sackeim et al, 2000).”
BackgroundElectroconvulsive therapy—efficacy and side-effects
Moksnes, K. M., & Ilner, S. O. (2010) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.1102 · Cited by 20
Right Unilateral Versus Bilateral Electroconvulsive Therapy in Patients With Clinical Depression
Saeed, M., Sher, Z., Khan, F., Iqbal, F., Siddiqui, T. A., Wahab, A., Khalid, I., Shamim, K., Dars, J. A., Farooqui, A., et al. (2021) · Cureus · doi:10.7759/cureus.18313 · Cited by 4
“ECT had been commonly practiced to treat a range of psychiatric illnesses, peculiarly severe depression; however, it has been replaced by oral medications in recent years [2].”
Background
Metadata
- Authors
- McCall, W. V.
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09
- Volume
- 4
- Issue
- 03
- Pages
- 315-24
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2148025438
- Cited by
- 74
- References
- 2
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electroconvulsive therapy in the era of modern psychopharmacology. https://app.cochat.ai/papers/10.1017/s1461145701002437
- The paper
- McCall, W. V. (2001). Electroconvulsive therapy in the era of modern psychopharmacology. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145701002437
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.